Literature DB >> 24212927

PTEN, here, there, everywhere.

C Bassi1, V Stambolic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24212927      PMCID： PMC3824593          DOI： 10.1038/cdd.2013.127

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  19 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.

Authors:  Y Wu; D Dowbenko; S Spencer; R Laura; J Lee; Q Gu; L A Lasky
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Pleckstrin domain homology.

Authors:  R J Haslam; H B Koide; B A Hemmings
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

5.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

6.  SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane.

Authors:  Jian Huang; Jie Yan; Jian Zhang; Shiguo Zhu; Yanli Wang; Ting Shi; Changhong Zhu; Cheng Chen; Xin Liu; Jinke Cheng; Tomas Mustelin; Gen-Sheng Feng; Guoqiang Chen; Jianxiu Yu
Journal:  Nat Commun       Date:  2012-06-19       Impact factor: 14.919

7.  PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.

Authors:  M Tamura; J Gu; E H Danen; T Takino; S Miyamoto; K M Yamada
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

9.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.

Authors:  Yvonne Lindsay; David McCoull; Lindsay Davidson; Nick R Leslie; Alison Fairservice; Alex Gray; John Lucocq; C Peter Downes
Journal:  J Cell Sci       Date:  2006-12-15       Impact factor: 5.285
View more
  9 in total

1.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

2.  Concerted roles of PTEN and ATM in controlling hematopoietic stem cell fitness and dormancy.

Authors:  Jerome Fortin; Christian Bassi; Parameswaran Ramachandran; Wanda Y Li; Ruxiao Tian; Ida Zarrabi; Graham Hill; Bryan E Snow; Jillian Haight; Chantal Tobin; Kelsey Hodgson; Andrew Wakeham; Vuk Stambolic; Tak W Mak
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 3.  Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction.

Authors:  Jeremy M Henley; Tim J Craig; Kevin A Wilkinson
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

4.  A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity.

Authors:  Anabel Gil; Isabel Rodríguez-Escudero; Miriam Stumpf; María Molina; Víctor J Cid; Rafael Pulido
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor.

Authors:  Praneeth R Kuninty; Linda Bojmar; Vegard Tjomsland; Marie Larsson; Gert Storm; Arne Östman; Per Sandström; Jai Prakash
Journal:  Oncotarget       Date:  2016-03-29

6.  High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.

Authors:  Synnøve Yndestad; Eilin Austreid; Stian Knappskog; Ranjan Chrisanthar; Peer Kåre Lilleng; Per Eystein Lønning; Hans Petter Eikesdal
Journal:  Breast Cancer Res Treat       Date:  2017-02-17       Impact factor: 4.872

7.  Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.

Authors:  Barak Rotblat; Thomas G P Grunewald; Gabriel Leprivier; Gerry Melino; Richard A Knight
Journal:  Oncotarget       Date:  2013-12

Review 8.  PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.

Authors:  Nahal Haddadi; Yiguang Lin; Glena Travis; Ann M Simpson; Najah T Nassif; Eileen M McGowan
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

9.  Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN-/- mutant.

Authors:  Daniel F Lusche; Emma C Buchele; Kanoe B Russell; Benjamin A Soll; Michele I Vitolo; Michael R Klemme; Deborah J Wessels; David R Soll
Journal:  Oncotarget       Date:  2018-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.